Breast Neoplasm

Breast neoplasm is a growth in the breast that is abnormal in nature. Neoplasms are not necessarily malignant, but diagnostic tests are usually needed to learn more about the nature of the growth and to develop an appropriate treatment plan.

Showing 1–12 of 23 results

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
1
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price from
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
2018.06
212,00 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
2018.09
212,00 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
2018.09
212,00 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
2018.12
212,00 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
2019.03
212,00 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
2019.08
212,00 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
2019.10
212,00 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
yes
2 mg
-80°C
2021.03
212,00 
view product
Max: 6
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
3 mg
-80°C
2017.09
267,00 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
3 mg
-80°C
2018.03
267,00 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
12.5 mg
-80°C
2024.06
367,00 
view product
Max: 10
Min: 1
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
yes
2 mg
-80°C
2024.07
212,00 
view product
Max: 10
Min: 2
Step: 1
HER2
Biosimilar
,
Monoclonal Antibody
Herzuma®
21 mg/mL
6 mg
tba
tba
356,00 
view product
Max:
Min: 7
Step: 1
HER2
Biosimilar
,
Monoclonal Antibody
Ontruzant®
21 mg/mL
2 mg
tba
tba
159,00 
view product
Max:
Min: 15
Step: 1
HER2
Biosimilar
,
Monoclonal Antibody
Kanjinti®
21 mg/mL
6 mg
-80°C
2025.01
367,00 
view product
Max: 10
Min: 1
Step: 1
HER2
Biosimilar
,
Monoclonal Antibody
Zercepac®
21 mg/mL
6 mg
-80°C
2026.08
367,00 
view product
Max: 10
Min: 1
Step: 1
HER2
Biosimilar
,
Monoclonal Antibody
Ogivri®
21 mg/mL
6 mg
-80°C
2025.10
451,00 
view product
Max: 10
Min: 1
Step: 1
HER2
Biosimilar
,
Monoclonal Antibody
Trazimera®
21 mg/mL
2 mg
-80 °C
2026.09
164,00 
view product
Max: 10
Min: 2
Step: 1
HER2
Monoclonal Antibody
Herceptin®
21 mg/mL
2 mg
-80°C
2020.08
169,00 
view product
Max: 10
Min: 2
Step: 1
HER2
Monoclonal Antibody
Herceptin®
21 mg/mL
2 mg
-80°C
2021.02
169,00 
view product
Max: 10
Min: 2
Step: 1
HER2
Monoclonal Antibody
Herceptin®
21 mg/mL
2 mg
-80°C
2021.08
169,00 
view product
Max: 7
Min: 2
Step: 1
HER2
Monoclonal Antibody
Herceptin®
21 mg/mL
2 mg
-80°C
2026.12
169,00 
view product
Max: 10
Min: 2
Step: 1
HER2
Monoclonal Antibody
Herceptin®
21 mg/mL
2 mg
-80°C
2020.12
169,00 
view product
Max: 10
Min: 2
Step: 1

Not looking for Breast Neoplasm?

Search our therapeutic molecules product database